PNC Financial Services Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

PNC Financial Services Group’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$448K	Buy	856 +579	+209%	+$277K	﹤0.01%	1757
2025 Q4	$161K	Buy	277 +15	+6%	+$7.66K	﹤0.01%	2455
2025 Q3	$120K	Buy	262 +19	+8%	+$7.09K	﹤0.01%	2675
2025 Q2	$73.5K	Sell	243 -130	-35%	-$38.7K	﹤0.01%	2905
2025 Q1	$124K	Sell	373 -1	-0.3%	-$329	﹤0.01%	2521
2024 Q4	$115K	Buy	374 +4	+1%	+$1.13K	﹤0.01%	2596
2024 Q3	$78.5K	Sell	370 -5	-1%	-$1.28K	﹤0.01%	2819
2024 Q2	$105K	Buy	375 +39	+12%	+$9.28K	﹤0.01%	2601
2024 Q1	$89.7K	Buy	336 +241	+254%	+$56.8K	﹤0.01%	2671
2023 Q4	$22K	Buy	95 +20	+27%	+$3.5K	﹤0.01%	3384
2023 Q3	$11K	Buy	75 +21	+39%	+$3.95K	﹤0.01%	3715
2023 Q2	$12.5K	Buy	54 +40	+286%	+$10.8K	﹤0.01%	3774
2023 Q1	$3.39K	Hold	14	–	–	﹤0.01%	4167
2022 Q4	$4.06K	Hold	14	–	–	﹤0.01%	4062
2022 Q3	$0	Hold	14	–	–	﹤0.01%	4544
2022 Q2	$2K	Hold	14	–	–	﹤0.01%	4218
2022 Q1	$2K	Sell	14 -6	-30%	-$506	﹤0.01%	4205
2021 Q4	$3K	Buy	20 +1	+5%	+$82	﹤0.01%	4080
2021 Q3	$2K	Sell	19 -1	-5%	-$86	﹤0.01%	4120
2021 Q2	$2K	Sell	20 -2	-9%	-$237	﹤0.01%	4042
2021 Q1	$2K	Buy	22 +2	+10%	+$233	﹤0.01%	3959
2020 Q4	$2K	Hold	20	–	–	﹤0.01%	3845
2020 Q3	$2K	Hold	20	–	–	﹤0.01%	3816
2020 Q2	$2K	Buy	20 +6	+43%	+$590	﹤0.01%	3778
2020 Q1	$0	Hold	14	–	–	﹤0.01%	3989
2019 Q4	$2K	Hold	14	–	–	﹤0.01%	3796
2019 Q3	$2K	Hold	14	–	–	﹤0.01%	3864
2019 Q2	$2K	Hold	14	–	–	﹤0.01%	3872
2019 Q1	$2K	Hold	14	–	–	﹤0.01%	3881
2018 Q4	$2K	Sell	14 -1,357	-99%	-$210K	﹤0.01%	3865
2018 Q3	$293K	Sell	1,371 -15	-1%	-$3.76K	﹤0.01%	1970
2018 Q2	$387K	Sell	1,386 -519	-27%	-$91.1K	﹤0.01%	1799
2018 Q1	$223K	Buy	+1,905	New	+$235K	﹤0.01%	2105
2016 Q3	–	Sell	-73	Closed	-$1K	–	4149
2016 Q2	$1K	Sell	73 -3	-4%	-$36	﹤0.01%	4360
2016 Q1	$1K	Buy	76 +3	+4%	+$25	﹤0.01%	4370
2015 Q4	$1K	Buy	73 +61	+508%	+$1.67K	﹤0.01%	4337
2015 Q3	$1K	Hold	12	–	–	﹤0.01%	4472
2015 Q2	$1K	Hold	12	–	–	﹤0.01%	4557
2015 Q1	$1K	Hold	12	–	–	﹤0.01%	4495
2014 Q4	$1K	Sell	12 -129	-91%	-$13.3K	﹤0.01%	3999
2014 Q3	$15K	Hold	141	–	–	﹤0.01%	3156
2014 Q2	$20K	Hold	141	–	–	﹤0.01%	2925
2014 Q1	$21K	Buy	141 +27	+24%	+$5.32K	﹤0.01%	2836
2013 Q4	$21K	Hold	114	–	–	﹤0.01%	2783
2013 Q3	$25K	Hold	114	–	–	﹤0.01%	2755
2013 Q2	$20K	Buy	+114	New	+$29.7K	﹤0.01%	2743

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PNC Financial Services Group's MDGL Position: Q1 2026 in Review

PNC Financial Services Group increased its Madrigal Pharmaceuticals (MDGL) stake by 209% in Q1 2026, buying an estimated $277K and bringing the position to 856 shares worth $448K. The position accounts for ﹤0.01% of the portfolio, ranked #1757.

PNC Financial Services Group first reported a position in MDGL in Q2 2013 and has held it in 46 quarters since. 378 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

PNC Financial Services Group held 856 shares of Madrigal Pharmaceuticals worth $448K as of Q1 2026.
PNC Financial Services Group bought 579 Madrigal Pharmaceuticals shares in Q1 2026, an estimated $277K.
Madrigal Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #1757 holding.
PNC Financial Services Group first reported a position in Madrigal Pharmaceuticals in Q2 2013 and has held it in 46 quarters since.
378 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.